CD3E&CD3D hFc Chimera, Cynomolgus
CD3E&CD3D HFc Chimera, Cynomolgus

Immobilized CD3E&CD3D hFc Chimera, Cynomolgus, hFc Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-CD3 Antibody, hFc Tag with the EC50 of 50.0 ng/ml determined by ELISA.

CD3E&CD3D HFc Chimera, Cynomolgus

The purity of CD3E&CD3D hFc Chimera, Cynomolgus, Cynomolgus was greater than 95% as determined by SEC-HPLC.

CD3E&CD3D HFc Chimera, Cynomolgus

CD3E&CD3D hFc Chimera, Cynomolgus on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.

CD3E&CD3D hFc Chimera, Cynomolgus

T-cell surface glycoprotein CD3 epsilon&CD3 delta chain, also known as CD3E&CD3D, are single-pass type I membrane proteins. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain.
Z03998
¥76,483.00

Ask us a question
Product Introduction
Species Cynomolgus
Protein Construction
CD3E & CD3D [Gln22-Asp117 (CD3E) & Phe22-Ala105 (CD3D)]
Accession # Q95LI5.2 (CD3E) & Q95LI8 (CD3D)		 hFc
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Immobilized CD3E&CD3D hFc Chimera, Cynomolgus at 0.5μg/ml (100μl/well) on the plate can bind Biotinylated Anti-CD3E&CD3D Antibody, hFc Tag. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 36.9 kDa (CD3E) and 35.4 kDa (CD3D)
Apparent Molecular Weight Due to glycosylation, the protein migrates to 58-62 kDa (CD3E) and 44-46 kDa (CD3D) based on Bis-Tris PAGE result.
Formulation Lyophilized from a 0.22 μm filtered solution in PBS，(pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • CD3E&CD3D HFc Chimera, Cynomolgus
    • CD3E&CD3D HFc Chimera, Cynomolgus

    Immobilized CD3E&CD3D hFc Chimera, Cynomolgus, hFc Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-CD3 Antibody, hFc Tag with the EC50 of 50.0 ng/ml determined by ELISA.

  • CD3E&CD3D HFc Chimera, Cynomolgus
    • CD3E&CD3D HFc Chimera, Cynomolgus

    The purity of CD3E&CD3D hFc Chimera, Cynomolgus, Cynomolgus was greater than 95% as determined by SEC-HPLC.

  • CD3E&CD3D HFc Chimera, Cynomolgus
    • CD3E&CD3D HFc Chimera, Cynomolgus

    CD3E&CD3D hFc Chimera, Cynomolgus on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.


Background
Target Background T-cell surface glycoprotein CD3 epsilon&CD3 delta chain, also known as CD3E&CD3D, are single-pass type I membrane proteins. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain.
Synonyms CD3; CD3e; CD3E; CD3d; T3D; CD3D; CD3E&CD3D; CD3 delta&CD3 epsilon

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.